We have previously reported that an increase in the production of immunosuppressive prostaglandin E2 by a QR tumour 
by T cells and inhibits T-cell proliferative responses to mitogens (Walker et al., 1983; Young & Dizer, 1983) . Tumour-derived PGE2 promotes the in vivo growth of tumour cells by suppressing the host anti-tumour immune defences (Catalona & Chretien, 1973; Jessup et al., 1976; Anderson et al., 1981) . When prostaglandin levels in tumourbearing mice are reduced by the oral administration of an inhibitor of PGE2 synthesis, indomethacin, or by use of antibodies against PGE2, immunosuppression is also reduced and tumour development is significantly diminished (Lynch & Salomon, 1979; Young & Dizer, 1983; Young & Knies, 1984; Okada et al., 1990) . These studies reveal an evident parallelism between the level of PGE2 production and the growth and malignant progression of tumour cells (Rolland et al., 1990) .
We have previously reported that a clone (QR-32 cells) derived from a cultured mouse fibrosarcoma, BMT-l1 cl-9, spontaneously regresses in normal syngeneic C57BL/6 mice (Ishikawa et al., 1987a , Okada et al., 1990 . We considered that, because PGE2 suppressed the anti-tumour effector cell induction at the site of tumour implantation in the tumorgenic parental BMT-11 cl-9 cells, the regression of QR-32 cells was likely to be due to a decrease in the production of PGE2 (Okada et al., 1990 )_ We have also observed that oxygen radicals produced by host cells reactive to foreign bodies such as gelatin sponge augment the production of PGE2 by QR-32 cells during co-culture in vitro. The enhanced production of immunosuppressive PGE2 facilitates the progressive growth of tumours in normal mice when they are given a subcutaneous injection of mixtures of host cells reactive to gelatin sponge and QR-32 cells (Okada et al., 1992) . In our mouse tumour model, PGE2 acts not only to augment the in vivo growth of tumour cells but also as a positive factor for the chemotaxis of tumour cells, as well as enhancing QR-32 cell-derived progressor tumour cell migration and dissemination (Young et al., 1991) . In the present study, we have examined what kinds of anti-tumour effector cell are able to promote in vitro PGE2 production by QR-32 cells, and have attempted to determine whether oxygen radicals or cytokines are involved in the enhancement of PGE2 production by tumour cells.
Materials and

Twnour cells
The origin and characteristics of the tumour cells used in the experiments have been described previously (Ishikawa et al., 1987a,b; Okada et al., 1990) . Briefly, after exposure of the tumorigenic mouse fibrosarcoma BMT-11 cl-9 cells to quercetin and cloning by limiting dilution, we were able to obtain QR-32 clone cells which spontaneously regress in normal syngeneic C57BL/6 mice (Ishikawa et al., 1987a) .
In our previous study, we concluded that the in vivo regression of QR-32 cells is mainly due to a decrease in the production of immunosuppressive PGE2 as compared with the tumorigenic parent BMT-I 1 cl-9 cells, in which the induction of anti-tumour effector cells is suppressed at the site of tumour implantation (Okada et al., 1990) . We found that the threshold level of POE2 production necessary to suppress host immune reactivity in vivo is equivalent to approximately 6,000pgml-' of medium in vitro, a value which was produced by 1 x 104 tumour cells during a 48 h culture (Okada et al., 1990 (Okada et al., , 1992 . Japan). IL-6 was a kind gift from Professor T. Hirano, Osaka University. OK-432, the penicillin-treated Su strain of Streptococcus pyogenes, was donated by Chugai (Tokyo), of which the clinical unit is expressed as KE (1 KE = 0.1 mg dry weight of bacteria).
Culture conditions QR-32 cells and anti-tumour effector cells were co-cultered in Eagle's minimum essential medium supplemented with 8% fetal calf serum (inactivated at 56-C for 30min), sodium pyruvate, non-essential amino acids and L-glutamme, at 37C, in a humidified 5% carbon dioxide-95% air mixture.
Preparation of anti-tumour effector cells Cytotoxic T lymphocytes (CTLs) specific to QR-32 cells were obtained from a 5 day mixed lymphocytes and tumour cell culture (MLTC). LAK cells were obtained from a 6 day culture of normal splenocytes with r-IL-2 (1,000 U ml-'). We used Percoll gradients (Pharmacia LKB Biotechnology, Uppsala, Sweden) to isolate NK cells after centrifugation at 1,800 r.p.m. for 40 min from the normal splenocytes that floated in the interfaces between densities of 1.060 and 1.070 (Bossiet et al., 1981; Mizobe et al., 1982) . As our group has previously reported, more than 90% of the spkenocytes in BMT-l1 cl-9 tumour bearers are PMN leucocytes (Ishikawa et al., 1987b) . Mice were injected i.p. with the 0.4 KE streptococcal preparation, OK432, which activates peritoneal macrophages (Hojo & Hashimoto, 1981; Kawaguchi et al., 1983) . Seven days later, peritoneal exudate cells were collected, seeded into plastic plates and incubated for 1 h.
Plastic-adherent cells were used as activated macrophages.
Resident macrophages were collect by the same procedure as the activated macrophages except for the OK432 injection.
Details of the induction of anti-tumour effector cells have already been reported (Okada et al., 1990 ).
"'In-oxune-release assay Target QR-32 tumour cells were labelled with 0.1 mCi of "'In-oxine (Nihon Medi-Physics, Japan). Approximately 1 x 10' target cells were distributed into the wells of 96-well round-bottom microplates, to which various anti-tumour effector cells were added (effector-to-target cell ratios ranging from 200:1 to 1:1). Assays were performed in triplicate.
After 48 h incubation, the plates were centrifuged, and the radioactivity of the supernatant was measured with a gamma counter. Specific cytotoxicity was caculated by the following formula, where a is the value of "'In release due to the cytotoxicity of the effectors, b is the total "'In release caused by treatment with 1 M hydrochloric acid and c is the value of spontaneous release from target tumour cells incubated with medium alone:
The details of these assays have been described elsewhere (Kawata et al., 1990) .
"Cr-release assay Target QR-32 cells were labelled with 0.1 mCi of 5"Cr-sodium chromate (New England Nuclear, Boston, MA, USA). The labelled tumour cells were co-cultured with LAK cells for 6 h. The speific cytotoxicity and the procedures were the same as those indicated for the "'In-oxine-release assays. The details of these assays have been described elsewhere (Okada et al., 1990 (Mosmann, 1983) .
Preparation and radioimmunoassay for PGE2 Approximately 1 x 10' QR-32 cells were cultured with or without anti-tumour effector cells at various effector-totumour cell ratios in 24 well plastic plates in 2 ml of medium per well for 48 h, after which the supernatants were harvested. PGE2 production by QR-32 cells after co-culture with various doses of cytokines and growth factors was measured by the same procedure as the one described above. Supernatants were stored below -70-C until required for the assay for PGE2. The amounts of PGE2 in the samples were determined by a commercially available radioimmunoassay kit (New England Nuclear, Boston, MA, USA). Determinations were carried out in triplicate and the mean and standard deviations were obtained. The details of this assay have been described previously (Okada et al., 1990) .
Statistical analysis
The signifi of the differences in the PGE2 production was caculated by the Student's t-test. All experiments were repeated two or three times and the representative data were derived from one out of at least two experiments with similar results.
Res
Cytolysis of QR-32 cells by various anti-tumour effector cells
We examined the cytotoxicity of various anti-tumour effector cells such as CTL, LAK, NK, PMN and activated/resident macrophages against "'In-oxine-labelled QR-32 cells for 48 h. We observed that these anti-tumour effector cells lysed QR-32 cells to various degrees when the effector-to-target cell (El/) ratios ranged from 200:1 to 1:1 (Table I) .
Increased production ofprostaglandin E2 by QR-32 cells after co-culture with vwarious anti-twnour effector cells We co-cultured QR-32 cells (1 x 10') and each anti-tumour effector cell at various E/T ratios and measured the amounts of PGE2 (Figure 1 ). Sinificntly high levels of PGE2 production were observed when QR-32 cells were co-cultured with various anti-tumour effector cells even at low E/T ratios, whereas CTL specific to QR-32 cells did not induce PGE2
production. The amounts of PGE2 production caused by anti-tumour effector cells alone varied. QR-32 cells by themselves produced less than 2,550 pg ml-' PGE2. Since individual anti-tumour effector cells lysed QR-32 cells to various extents (Table I) , and since PGE2 production depended on the number of tumour cells, we compared PGE2 production at the E/T ratio at which an equal number of surviving tumour cells remain after co-culture with the individual anti-tumour effector cells. The data are summarised in 8,933 ± 603' macrophages 'PGE2 production was observed when 1 x 10' QR-32 cells were co-cultured with effector cells at an E/T ratio which produced about 30% lysis of the QR-32 cells. PGE2 levels in supernatants obtained from co-cultures in 24-well plastic plates for 48 h. 'The methods for the induction and coUlection of each effector cell are described in Table I , footnotes c-h, and in the Materials and methods section. cEffector-to-target ceUl ratio. dExpected values were calculated from the additive production of PGE2 by the tumour and effector cells. 'Significant increase in the observed production of PGE2 by the co-cultured cells was observed as compared with the expected values (P <0.001).
effector cells (P<0.001). On the other hand, PGE2 production by co-culture of tumour cells with CTLs is almost equal to the expected value. Not only QR-32 cells but also tumorigenic parental BMT-11 cl-9 cells, which produce large amounts of PGE2 by themselves, can be converted so as to produce much greater amounts of PGE2 after co-culture with anti-tumour effector cells (data not shown).
Inhibition of the increase in PGE2 production during QR-32 cell co-culture with anti-tumour effector cells in the presence of radical scavengers We examined the effect of radical scavengers on the PGE2 production of QR-32 cells enhanc by co-culturing them with anti-tumour effector cells (Figure 2 ). Superoxide dismutase (SOD, 300 U ml -) inhibited the increase in PGE2 production after QR-32 cells were co-cultured with LAK and PMN cells (P<0.001 and P<0.005, respectively), whereas SOD did not inhibit PGE2 production significantly after being co-cultured with NK cells or activated/resident macrophages. In the presence of catalase (20,000Uml-') and mannitol (5 x 10-2 M), PGE2 production was significntly inhibited when tumour cells were co-cultured with antitumour effector cells. As a positive controL PGE2 production was also inhibited after we added indomethacin (10-6 M), an inhibitor of prostaglandin synthesis.
Effects of oxygen radical scavengers on the cytolysis of QR-32 cells during co-culture with lymphokine-activated killer cells Since LAK cells produce various species of oxygen radicals in our system (Figure 2) , and sinc QR-32 cells have been shown to be highly sensitive to LAK cells even in a 6h 5'Cr-release assay (Olkada et al., 1990), we next examined the effects of oxygen radicals produced by LAK cells on the cytolysis of QR-32 cells (Table III) . The LAK cells' kIilling activities were not significantly reduced during co-culture with SOD, catalase and mannitol. No cytotoxic activity by radical scavengers on QR-32 cells was observed.
Increased production ofprostaglandin E2 after exposure of QR-32 cells to IFN-x AID, TNF-c and TGF-P We measured the PGE2-producing activity and enhancement of cell growth of QR-32 cells after their co-culture with various recombinant cytokines and growth factors. IL-1p, IL-2, IL-6, G-CSF, IFN-z A/D, TNF-a, TGF-a and -P, bFGF and EGF were diluted to 10-fold dilutions from high concentrations and 1 x 104 QR-32 cells were exposed to each dilution for 48 h, after which we masured the PGE2 in the catalase (20,000 U ml') or mannitol (5 x 10-2 M) for 48 h. Each E/T ratio which produced about 30% lysis of culture supernatants. Table IV shows typical data from one of at least two experiments. IFN-a A/D, TNF-x and TGF-P induced signifintly inc d PGE2 production by the QR-32 cells (P<0.001). Cell growth was inhibited by as much as 59.8% and 61.0% when QR-32 cells were exposed to 100 and lOngml-' IFN-x A/D respectively, by 54.8% and 77.7% when the cells were exposed to 1,000 and 100 U ml-' TNF-x resPectively and by 88.7% when the cells were exposed to IOngml-' TGF-P, all as compared with the growth of untreated QR-32 cells (100%). Other cytokines which did not induce QR-32 cells to produce large amounts of PGE2 did not inhibit the growth of QR-32 cells either.
In this study, we have been able to demonstrate that prostaglandin E2 (PGE2) production by QR-32 cells is augmented when the tumour cells are co-cultured with various antitumour effector cells at various effector-to-tumour cell ratios, with the exception of cytotoxic T lymphocytes (CTLs) specific to the tumour cells. Enhad PGE2 production by 24-well plastic plate with or without cytokine or growth factor. PGE2 production in culture supernatant after 48 h was measured. bPer cent cell growth when compared with non-treated cell growth assessed by 48 h MUT assay. 'P <0.001. dNot significant vs PGE2 production by QR-32 cells alone. tumour cells is considered to be an important mechanism for facilitating tumour cell escape from host immune surveillInmce. We have previously reported that QR-32 cells derived from tumorigenic BMT-l1 cl-9 cells, which produce large amounts of PGE2, find it hard to grow progressively in normal syngeneic mice because of a decrease in the production of PGE2 (Okada et al., 1990) . We have also observed that PGE2 acts not only as an immunosuppressive factor but also as a positive factor for the chemotactic and motile behaviour of tumour cells (Young et al., 1991) . These previous observations revealed that enhanced PGE2 production by tumour cells results in the malignant progression of the tumour cells (Okada et al., 1992) . QR-32 cells produce large amounts of PGE2 when the tumour cells have been co-cultured with foreign body-reactive cells (Okada et al., 1992) . In this study, we therefore attempted to determine which cell type of the anti-tumour effector cells is involved in the induction of QR-32 cell progression.
At (Thozz, 1993; Yasumura et al., 1993) . This would mean that only those tumour cells which do not make contact with CTLs can survive. On the other hand, although the antigen non-specific anti-tumour effector cells are able to kill a large proportion of the QR-32 cells, they would also affect the surviving tumour cells. We speculate, therefore, that surviving QR-32 cells, after contact with antigen non-specific anti-tumour effector cells, are converted so as to produce large amounts of PGE2. This speculation is supported by our finding that only cytotoxic cytokines (IFN-a, TNF-4 and TGF-P) enhanced PGE2 production by QR-32 cells (Table  MV) . Our preliminary data show that the surviving QR-32 cells, after in vitro co-culture with NK cells and LAK cells were converted to tumorigenic tumours in normal syngeneic mice after subcutaneous injection (data not shown). We believe that, under appropriate conditions, anti-tumour effector cells within tumour tissues might induce malignant progression of tumours through the enhanced production of PGE2 in the microenvironment surrounding the tumour cells. Regardless of whether this is so or not, it is nonetheless an important finding that anti-tumour effector cells may convert benign tumour cells into more malignant ones.
We have previously reported that oxygen radicals are involved in the mechanisms responsible for PGE2 production by tumour cells (Okada et al., 1992) . Results indicated that oxygen radicals might play a role in the in vivo malignant progression of QR-32 cells (Okada et al., 1993) . We observed in the present study that enhanced PGE2 production by QR-32 cells after co-culture with anti-tumour effector cells was inhibited in the presence of radical scavengers. We found that oxygen radicals produced by host effector cells induce somatic mutations in QR-32 cells (Okada et al., 1993) . However, the oxygen radicals produced by LAK cells do not seem to be enough to kill QR-32 cells, as we found when we added radical scavengers extracellularly to the co-culture system. Therefore, we speculate that the quantity of oxygen radicals required to alter tumour properties is much smaller than the quantity necessary for direct tumour cell killing.
We have observed that QR-32 cells can also be altered to produce large amounts of PGE2 when they are cultured with cytotoxic cytokines in the absence of anti-tumour effector cells. This finding is a strong indication that high levels of PGE2 production are caused mainly by the tumour cells themselves. We wish to conclude that the factors which stimulate PGE2 production by tumour cells are derived from anti-tumour effector cells and not from tumour cells themselves. Our findings lead us to suggest that an in vitro experimental system using QR-32 cells may be useful for the detection of tumour progression-enhancing factor(s).
